Anixa Biosciences, Inc. (ANIX)
3.29
+0.01
(+0.30%)
USD |
NASDAQ |
Jan 14, 16:00
3.29
0.00 (0.00%)
After-Hours: 20:00
Anixa Biosciences EPS Diluted (Quarterly): -0.0816 for Oct. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Merck & Co., Inc. | 2.316 |
| Boston Scientific Corp. | 0.5048 |
| Puma Biotechnology, Inc. | 0.1736 |
| Sensus Healthcare, Inc. | -0.0578 |
| CEL-SCI Corp. | -0.7611 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.722M |
| Total Expenses (Quarterly) | 2.695M |
| Enterprise Value | 93.29M |
| Earnings Yield | -10.23% |
| Normalized Earnings Yield | -10.23 |